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Parliament has criticised the British government over reluctance to 
sanction the creation of hybrid human stem cells for research. Nigel 
Williams reports.
UK battle over hybrid stem cellsBritish government plans to 
outlaw the creation of embryos 
which are part human, part animal 
are “unacceptable” and threaten 
to undermine the country’s leading 
position in stem-cell science, a 
group of MPs reported last month.
A report by the House of 
Commons science and technology 
committee called on ministers 
to scrap the proposed ban and 
accuses the government of basing 
its opposition to the research on a 
“deeply flawed” consultation.
Many scientists believe the 
research will pave the way for 
new treatments of diseases such 
as Alzheimer’s, Parkinson’s, and 
cystic fibrosis. They want to 
create animal–human embryos 
to understand the molecular 
details behind these conditions. 
The researchers would take a cell 
from a patient and insert it into a 
hollowed out cow or rabbit egg 
and stimulate it with a charge of 
electricity. The two cells then fuse 
to make an embryo which is 99.9 
per cent human and 0.1 per cent 
animal. Embryonic stem cells 
extracted from the embryo could 
be grown into nerves and other 
tissues, giving scientists insights 
into how the disease develops. 
Under existing laws, the embryos 
must be destroyed no later than 14 
days old and cannot be implanted.
Using plentiful animal eggs will 
allow researchers to overcome a 
major stumbling block caused by 
the shortage of fresh human eggs 
that would otherwise be needed 
for the work. The proposed ban 
has already drawn criticism from 
scientists, including Sir David 
King, the government’s chief 
scientific adviser, the Human 
Genetics Commission, the 
Medical Research Council and 
the Wellcome Trust.
Plans to outlaw the research 
were revealed in December by the 
public health minister in a white 
paper which has become the basis of a wide-ranging overhaul 
of fertility laws. It recommends 
a blanket ban on the creation of 
embryos which are part animal, 
part human, with a provision for 
some research in the area to be 
conducted under licence.
At a briefing in London, the 
committee chairman, Phil Willis, 
criticised the public consultation 
exercise used to defend the plan. 
The consultation attracted around 
300 responses with 277 opposed 
to research.The MPs called for permissive 
legislation, allowing research 
into human–animal embryos to 
go ahead under licence after 
scrutiny by the fertility regulator, 
the Human Fertilisation and 
Embryology Authority. The 
technique was pioneered by Hui 
Sheng, a developmental biologist 
in Shanghai. Researchers at 
Newcastle University and King’s 
College London have already 
applied to the HFEA to create 
animal–human embryos for 
stem- cell research.
The committee strongly 
criticised the HFEA for not taking 
a timely decision on processing Out of bounds: The British government is not allowing the creation of human–animal 
hybrid stem cells, in spite of lobbying from many research bodies. (Picture: James 
King-Holmes/Science Photo Library.)
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Butterflies are being increasingly 
recognised as an efficient means 
of protecting and monitoring 
wider ecosystem conditions. 
Conservationists in Europe point 
to work on the Bay Checkerspot 
in central California which is now 
regarded as an ‘umbrella’ species: 
if they are protected, other 
species will be preserved. The 
butterfly thrives only in the native 
grasslands of central California, 
which are severely threatened 
by alien plant species and urban 
development. Conservation 
efforts in the region focus on the 
Bay Checkerspot because studies 
have shown that, by conserving 
the butterfly, around 98 per cent 
of the native spring-flowering 
plant species will receive a 
measure of protection.
Many governments have signed 
up to the Global Convention 
on Biological Diversity with 
an ambitious target of halting 
biodiversity loss by 2010 but are 
looking for assessment measures 
to help meet this target.
Even in the best resourced 
countries with the best historical 
records, such as the UK, there 
are insufficient resources and 
knowledge to monitor every 
species and habitat. To overcome 
the problem, ecologists have 
sought to develop biodiversity 
indicators — species, or groups 
of species, that can provide 
surrogate measures for a wider 
range of species.
It is now increasingly clear that 
butterflies are often ideally suited 
to this role. 
They respond rapidly and 
sensitively to subtle habitat or 
climate changes, which means 
that they act as representatives 
for the diversity and responses of 
other less-visible wildlife.
Plans are now under way to 
use data from transect studies, 
which have a long-standing role 
in monitoring butterfly numbers, 
in ten countries within the EU to 
develop a proposed European 
Butterfly Indicator that will help 
assess progress by the EU in 
halting biodiversity loss.
The new status has pleased the 
British wildlife charity, Butterfly 
Conservation. “The government’s 
adoption of butterflies is a 
significant achievement,” it says. 
“It puts the plight of butterflies 
far higher up the political 
agenda. The hope is that the new 
indicators will lead to a firmer 
policy commitment to address 
butterfly declines.”
Butterflies find a new role as 
sensitive markers of wider 
environmental conditions. Nigel 
Williams reports.
Insect beacons
Health check: The Bay Checkerspot is helping US researchers monitor threatened natu-
ral habitat in central California. (Photo: T.W. Davies © California Academy of Sciences.)the applications, thereby delaying 
the start of this important 
research.
Willis said: “This is a test of 
the government’s commitment 
to science. Scientists, funders, 
the regulator and patient interest 
groups, even the DTI and the 
prime minister, have spoken 
out against the Department of 
Health’s proposals. We very much 
hope that the department will 
listen and reflect the committee’s 
conclusions when the draft Tissue 
and Embryos Bill is published 
next month.”
“We fully appreciate the 
concerns of those who oppose 
research into hybrid and chimera 
embryos — or indeed any human 
embryos — on moral and ethical 
grounds, but we feel that it is 
in the interests of science, the 
public and the UK that the current 
applications by King’s College 
London and Newcastle University 
should be considered by the 
HFEA promptly and with due 
process.”
Committee member Evan 
Harris said: “Ministers have never 
provided a rational basis for their 
ban and their only supporters are 
pro-life groups and anti-science 
campaigners who oppose all 
embryo research.”
In a letter to the prime 
minister, the Association of 
Medical Research Charities 
(AMRC) said there had been 
growing disquiet about an 
outright ban. Spokeswoman 
Sophie Petit- Zeman said: 
“To our knowledge, a letter 
to government signed by 223 
medical research charities 
and patient organisations is 
unprecedented.”
She said the AMRC respected 
the sensitivity of the issue 
but that it was important to 
balance the concerns against 
the medical benefits. Chris 
Shaw, a neurologist at King’s 
College London and one of 
the researchers who applied 
for a licence to create hybrid 
embryos said: “The committee’s 
recommendations show that 
when people really understand 
the work involved, and the 
potential benefits, that the law 
can be used to regulate and not 
restrict science in this field.”
